Pediatric Catheters Market Size, Share & Trends Analysis Report By Product (Urology, Cardiovascular, Intravenous, Neurovascular, Specialty), By Region, And Segment Forecasts, 2019 - 2025

Report Overview

The global pediatric catheters market size was valued at USD 5.1 billion in 2018 and is anticipated to expand at a 9.3% CAGR from 2019 to 2025. Growth in the pediatric population, rise in congenital heart defects (CHD), neurological disorders, and urinary tract infections, and lack of adequate newborn screening centers in emerging countries are some of the factors promoting demand for pediatric catheters.

Moreover, due to the increasing incidence of cardiovascular and urological diseases in the pediatric population, demand for minimally invasive surgeries is rising, which include the use of catheters for surgical and diagnostic procedures. Also, technological advancements observed in pediatric catheters are anticipated to eliminate its associated infections in children and increase the demand for the use of catheters over the forecast period.

Furthermore, various governments initiatives across the globe aimed to provide medical cover to millions of new patients, and programs such as Child Health Insurance Program (CHIP) in the U.S., which provides 365-day healthcare coverage to children, are anticipated to boost the adoption of the pediatric catheters over the forecast period.

Advanced healthcare infrastructure and favorable federal initiatives about the development of pediatric devices are likely to boost the market in North America. Rising incidence of congenital heart defects and urological problems in the region is also anticipated to emerge as a high-impact rendering factor in the market. The Asia Pacific is also projected to witness significant growth in the market owing to increasing prevalence rate of birth defects and expanding public and private healthcare infrastructure.

Pediatric Catheters Market Trends

Pediatric catheters are used to solve the issues that come with catheterization in youngsters. The design of a pediatric catheter is unique, and it is frequently made of different materials. These help in the treatment of dysfunctional bladders caused by spinal cord damage, spina bifida, diabetes, stroke, Parkinson's disease, or incontinence. Due to the increased number of venous thromboembolism (VTE) in the pediatric population, the use of these devices has expanded globally. The ease of installation and inexpensive cost of these catheters are anticipated to drive the market demand.

Instances of alcohol and drug abuse during pregnancy are on the rise, raising the risk of congenital cardiovascular problems in newborns. Its prevalence is also linked to genetic predisposition. Urology gadgets are expected to be in high demand as more youngsters have urological diseases that necessitate rapid surgical intervention. The availability of numerous sizes for children of various ages, as well as a good ergonomic design, benefits in the post-surgery recovery process, and improved patient satisfaction is driving the market growth.

A lack of information about pediatric catheters in low to middle countries is expected to hamper industry expansion. Limited reimbursement regulations and the expensive demand for doctors also limit the market's growth. In addition, the preference for drugs over medical equipment is anticipated to hinder market expansion.

Many of the major manufacturers are focusing on pediatric device research and innovation, which will help to expand their reach and attract a larger customer base. To strengthen their market positions, these suppliers use a variety of techniques, including product line expansion, acquisitions, and alliances. New product releases and technical innovations such as big analytics and robotics are expected to increase competition in the global market leading to maximizing opportunities in the market.

The COVID-19 outbreak has boosted the demand for pediatric catheter devices as the American College of Cardiology (ACC) found that 40% of COVID-19 recovered patients faced cardiovascular issues. This increased the usage of the devices due to the rising demand for IVUS actions during PCI procedures and the growing adoption of IVUS systems in diagnostic centers and hospitals.

Product Insights

In 2018, cardiovascular catheters used in pediatric cardiac interventions held the largest market share of 40.5% in terms of revenue. Congenital heart defects are one of the major reasons for high mortality in the pediatric population. The presence of a wide range of catheters for various interventional cardiology procedures is a key factor driving the segment.

Urology catheters are expected to emerge as the fastest-growing segment with a CAGR of 10.0% from 2019 to 2025. This high growth is anticipated on account of the increasing prevalence of bladder, urethra, uterus, and kidney problems in the pediatric population. Urology catheters are thin, hollow, plastic tubes used to drain out urine from the bladder. The catheter is inserted into the bladder through the urethra. It is often used after operations for the urinary system as it allows the healing process. It aids in treatments related to kidney, bladder, urethra, and reproductive organs. Discomfort related to the catheterization of the urinary tract is minimized by the use of the appropriate size of catheters in the pediatric population.

The use of catheters and their appropriate size varies with the age group of children. Thus, increasing prevalence of urology diseases, such as urinary tract infections in infants, is driving the pediatric catheters market. Other products such as neurovascular, intravenous, and specialty catheters are also anticipated to expand at a high CAGR owing to the increasing incidence of corresponding diseases in children, which require the use of these catheters for diagnosis and treatment.

Regional Insights

North America dominated the market in 2018 with a revenue of USD 1.8 billion and is expected to exhibit a high CAGR over the forecast period. The Asia Pacific, on the other hand, is anticipated to expand at the fastest CAGR of 11.3 % over the forecast period. Some of the key factors responsible for the high market share of North America are the growing prevalence of congenital heart defects and urological problems and rising inpatient and emergency room procedures.

According to the estimates published by the U.S. Centers for Disease Control and Prevention (CDC), in 2014, one in four babies are born with heart defects and about 25% of newborns possess critical congenital heart defects that necessitate surgeries or other interventions to increase their chances of survival in the first year of their life. Moreover, the presence of advanced healthcare facilities, strong reimbursement scenario, and favorable federal initiatives to encourage pediatric device development are anticipated to positively reinforce the growth in this region.

The Asia Pacific reported the highest prevalence rate of birth defects. According to estimates by the Asian Hospital and Healthcare Management, the prevalence rate of CHD accounted for 9.3 per 1000 live births with a significantly high occurrence of pulmonary outflow obstructions and ventricular septal defects. The increasing prevalence of congenital heart defects and other anomalies in low and middle-income countries is fueling the growth of this market. Moreover, expanding public and private healthcare infrastructure is expected to boost revenue growth.

Key Companies & Market Share Insights

The market consists of a large number of key players such as Cook Medical; Smiths Medical; Edwards Life Sciences Corporation; Medtronic Inc.; and Johnson & Johnson. These companies implement various inorganic growth strategies, such as acquisitions, and organic growth strategies, such as the expansion of the product portfolio, to increase their market reach and presence. New product launches, along with technological advancements by market players, are expected to increase the competition in the market over the forecast period. For instance, Cure Medical recently launched a 10-inch pediatric hydrophilic cure catheter, which is easy to use and does not kink when bent.

Recent Developments

• In May 2022, Cook Medical, a medical devices manufacturer, launched the MINC+TM benchtop incubator. This incubator is a part of assisted reproductive technology. These incubators are provided for IVF clinics in the US and Canada.

• In May 2022, Aesculap, Inc., a B. Braun Melsungen AG, secures exclusive and long-term distribution rights for a jointly developed digital surgical microscope named AesculapAeos. The agreement was done between Aesculap AG and True Digital Surgery, Inc.

• In March 2022, B. Braun Melsungen AG has acquired IntermedtMedizin and Technik GmbH. By this B. Braun has completed its wide product portfolio as a systems supplier for extracorporeal blood therapy through its B. Braun Avitum branch. This has been done to provide their clients with all dialysis goods and services available from a single source, as well as to streamline dialysis therapy operations through automation and digitalization.

Pediatric Catheters Market Report Scope

Pediatric Catheters Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For this study, Grand View Research has segmented the global pediatric catheters market report based on product and region.

• Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Cardiovascular

  • Urology

  • Intravenous

  • Neurovascular

  • Specialty

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • Spain

    • France

    • Italy

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Singapore

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE